In the current study, we validated the presence of autoantibodies to ZNF346, ZNF638, ZNF700 and ZNF768 in colorectal cancer in an independent and larger patient cohort using the well-established ELISA platform. This evidence concerns the gene ZNF638 and colorectal cancer.